These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15206526)

  • 1. Lot consistency as an equivalence problem.
    Lachenbruch PA; Rida W; Kou J
    J Biopharm Stat; 2004 May; 14(2):275-90. PubMed ID: 15206526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample size for equivalence trials: a case study from a vaccine lot consistency trial.
    Ganju J; Izu A; Anemona A
    Stat Med; 2008 Aug; 27(19):3743-54. PubMed ID: 18416439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The determination of equivalent doses of standardized allergen vaccines.
    Slater JE; Pastor RW
    J Allergy Clin Immunol; 2000 Mar; 105(3):468-74. PubMed ID: 10719295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comments on 'Sample size for equivalence trials: A case study from a vaccine lot consistency trial' by J. Ganju, A. Izu and A. Anemona, Statistics in Medicine 2008; 27:3743-3754.
    Kohberger RC
    Stat Med; 2009 Jan; 28(1):177-8, author reply 178-9. PubMed ID: 18937271
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical considerations for noninferiority/equivalence trials in vaccine development.
    Wang WW; Mehrotra DV; Chan IS; Heyse JF
    J Biopharm Stat; 2006; 16(4):429-41. PubMed ID: 16892905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
    Tsong Y; Shen M
    J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tracking vaccine lot lifecycles using reports to the vaccine adverse event reporting system (VAERS).
    Dayan GH; Iskander J; Glasser J; English-Bullard R; Fullerton KE; Chen R
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):671-6. PubMed ID: 15662715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific statistical considerations relevant to the design and analysis of gingivitis trials demonstrating product superiority or equivalence.
    Kingman A
    J Periodontal Res; 1992 Jul; 27(4 Pt 2):378-89; discussion 390-4. PubMed ID: 1507027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards eliminating the use of animals for regulatory required vaccine quality control.
    Hendriksen CF
    ALTEX; 2006; 23(3):187-90. PubMed ID: 17086348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tests of equivalence and non-inferiority for diagnostic accuracy based on the paired areas under ROC curves.
    Liu JP; Ma MC; Wu CY; Tai JY
    Stat Med; 2006 Apr; 25(7):1219-38. PubMed ID: 16158400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating statistical methods to establish clinical similarity of two biologics.
    Lei L; Olson K
    J Biopharm Stat; 2010 Jan; 20(1):62-74. PubMed ID: 20077249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint equivalence of means and variances of two populations.
    Grieve AP
    J Biopharm Stat; 1998 Jul; 8(3):377-90. PubMed ID: 9741854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new equivalence based metric for predictive check to qualify mixed-effects models.
    Jadhav PR; Gobburu JV
    AAPS J; 2005 Oct; 7(3):E523-31. PubMed ID: 16353930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing for individual and population equivalence based on the proportion of similar responses.
    Rom DM; Hwang E
    Stat Med; 1996 Jul; 15(14):1489-505. PubMed ID: 8855476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of non-compliance on intent-to-treat analysis of equivalence trials.
    Sheng D; Kim MY
    Stat Med; 2006 Apr; 25(7):1183-99. PubMed ID: 16220491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A confirmatory strategy for therapeutic equivalence trials.
    Kieser M
    Int J Clin Pharmacol Ther; 1995 Jul; 33(7):388-90. PubMed ID: 7582393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consistency testing of diphtheria and tetanus to replace potency testing for lot release.
    Kreeftenberg JG
    Dev Biol (Basel); 2002; 111():291-8. PubMed ID: 12678252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tests for equivalence based on odds ratio for matched-pair design.
    Liu JP; Fan HY; Ma MC
    J Biopharm Stat; 2005; 15(6):889-901. PubMed ID: 16279349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The consistency approach for the quality control of vaccines.
    Hendriksen C; Arciniega JL; Bruckner L; Chevalier M; Coppens E; Descamps J; Duchêne M; Dusek DM; Halder M; Kreeftenberg H; Maes A; Redhead K; Ravetkar SD; Spieser JM; Swam H
    Biologicals; 2008 Jan; 36(1):73-7. PubMed ID: 17892948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lessons learned from a review of the development of selected vaccines. National Vaccine Advisory Committee.
    Peter G; des Vignes-Kendrick M; Eickhoff TC; Fine A; Galvin V; Levine MM; Maldonado YA; Marcuse EK; Monath TP; Osborn JE; Plotkin S; Poland GA; Quinlisk MP; Smith DR; Sokol M; Soland DB; Whitley-Williams PN; Williamson DE; Breiman RF
    Pediatrics; 1999 Oct; 104(4 Pt 1):942-50. PubMed ID: 10506239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.